Una de las mayores metas de Life4me+ — prevenir nuevos casos de VIH y otras ITS, hepatitis C y tuberculosis.

El app ayuda a establecer una comunicación anónima entre médicos y personas vih+. Te permite organizar tu horario de toma de tratamiento de manera conveniente y fijar recordatorios personalizados que se pueden ocultar.

Todas las noticias / Enero 2019

Archivo

✕

17 enero 2019

4959

HIV infection named by WHO one of the main threats to human health in 2019

HIV infection named by WHO one of the main threats to human health in 2019

The World Health Organization announced this week the top ten key threats to human health for the coming year. The main problems are dirty air, noncommunicable diseases and drug resistant tuberculosis. HIV infection closes the list.

15 enero 2019

4343

In the USA will experience a new payment model for the treatment of hepatitis C

In the USA will experience a new payment model for the treatment of hepatitis C

According to the Washington Post, the authorities in Louisiana (USA) intend to use the new payment format for treating patients with hepatitis C, which the American Medical Association (JAMA) magazine previously called the Netflix model. The method of payment for treatment ...

15 enero 2019

4666

UNAIDS has called for financial support for the Global Fund

UNAIDS has called for financial support for the Global Fund

The Global Fund to Fight AIDS, Tuberculosis and Malaria (GF) announced the launch of the investment program "Sixth Replenishment" in the three-year funding cycle. UNAIDS has encouraged donors to support the fund.

14 enero 2019

4732

Global Fund: another £ 11 billion required for progress on HIV, TB and malaria

Global Fund: another £ 11 billion required for progress on HIV, TB and malaria

The world's largest fund to finance measures to combat HIV infection, tuberculosis and malaria, is seeking investment in the amount of 11 billion pounds sterling. At the end of last week, French President Emmanuel Macron called this move “decisive” and launched the last ...

14 enero 2019

4337

One of the HIV proteins is able to slow down the movement of infected T-cells and increase the survival rate of the virus

One of the HIV proteins is able to slow down the movement of infected T-cells and increase the survival rate of the virus

A group of scientists from the Massachusetts General Hospital (MGH) conducted a study that revealed the specific function of the Nef protein, which is part of the HIV structure, which, according to them, slows the spread of the virus in the very early stages of the infection, ...

12 enero 2019

5055

UK doubles PrEP participants

UK doubles PrEP participants

The UK health authorities this Friday said they support a plan to double the number of people participating in research on the efficacy of pre-exposure prophylaxis for HIV (PrEP). The authorities of the country are talking about a possible increase in the number of participants ...

11 enero 2019

5893

MSD could not challenge Gilead’s rights to sofosbuvir in court

MSD could not challenge Gilead’s rights to sofosbuvir in court

The American pharmaceutical company Merck (outside the US and Canada - MSD) was unable to appeal against patents of Gilead for the drug for the treatment of hepatitis C sofosbuvir. The US Supreme Court rejected the appeal of an organization demanding compensation for violating ...

1 2